Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:58 pm Sale |
2024-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
6,034,239 8.700% |
-1,043,239 (-14.74%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 6,859,823 9.800% |
940,388 (+15.89%) |
Filing History |
| 2024-11-14 3:59 pm Purchase |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
7,077,478 10.200% |
127,060 (+1.83%) |
Filing History |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
PRICE T ROWE ASSOCIATES INC | 3,808,359 5.500% |
127,150 (+3.45%) |
Filing History |
| 2024-11-14 06:51 am Purchase |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 5,919,435 8.500% |
2,326,676 (+64.76%) |
Filing History |
| 2024-11-13 09:45 am Sale |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
ALKEON CAPITAL MANAGEMENT LLC | 3,325,004 4.800% |
-439,216 (-11.67%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
WELLINGTON MANAGEMENT CO LLP | 7,896,632 11.370% |
867,008 (+12.33%) |
Filing History |
| 2024-10-17 11:13 am Sale |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
STATE STREET CORP STT |
2,502,946 3.600% |
-2,619,949 (-51.14%) |
Filing History |
| 2024-09-09 09:09 am Purchase |
2024-08-30 | 13G | Akero Therapeutics, Inc. AKRO |
WELLINGTON MANAGEMENT CO LLP | 7,029,624 10.120% |
4,147,635 (+143.92%) |
Filing History |
| 2024-06-10 4:17 pm Purchase |
2024-05-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
6,950,418 10.100% |
2,644,017 (+61.40%) |
Filing History |
| 2024-03-15 10:08 am Purchase |
2024-03-06 | 13G | Akero Therapeutics, Inc. AKRO |
GENERAL ATLANTIC PARTNERS LLC | 5,233,989 7.700% |
5,233,989 (New Position) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Redmile Group LLC | 1,109,476 2.000% |
-1,523,436 (-57.86%) |
Filing History |
| 2024-02-14 4:21 pm Unchanged |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Baker Bros. Advisors LP | 2,368,378 4.300% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:19 pm Unchanged |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
PFIZER INC PFE |
2,525,252 4.530% |
0 (Unchanged) |
Filing History |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
PRICE T ROWE ASSOCIATES INC | 3,681,209 6.600% |
1,280,172 (+53.32%) |
Filing History |
| 2024-02-14 07:06 am Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 3,592,759 6.400% |
3,592,759 (New Position) |
Filing History |
| 2024-02-13 9:40 pm Sale |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Avidity Partners Management LP | 235,000 0.400% |
-3,590,000 (-93.86%) |
Filing History |
| 2024-02-13 6:30 pm Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
ALKEON CAPITAL MANAGEMENT LLC | 3,764,220 6.800% |
520,305 (+16.04%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Akero Therapeutics, Inc. AKRO |
The Vanguard Group | 3,085,048 5.540% |
3,085,048 (New Position) |
Filing History |
| 2024-02-13 11:31 am Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
4,306,401 7.700% |
966,227 (+28.93%) |
Filing History |